Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06074445
Other study ID # Ethics ID 39453
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 23, 2022
Est. completion date September 30, 2022

Study information

Verified date October 2023
Source Bournemouth University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of this survey study is to provide broad information as reported by cancer survivors and their intimate partners about both their sexual health and their experiences of care from the United Kingdom hospital cancer team, including their perspectives on factors that may hinder or help care. This information will be analysed and used to inform the questions asked in a separate, subsequent, qualitative study.


Recruitment information / eligibility

Status Completed
Enrollment 169
Est. completion date September 30, 2022
Est. primary completion date September 30, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Cancer survivors diagnosed with any type of cancer at age 18 years or over 2. A partner of someone diagnosed with any type of cancer at age 18 years or over 3. Cancer diagnosis must be no more than 10 years ago 4. Cancer survivors or their partners who experienced treatment and follow up care in the United Kingdom Exclusion Criteria: 1. Cancer survivors who were diagnosed with cancer below the age of 18 years 2. Partners of cancer survivors who were diagnosed with cancer below the age of 18 years 3. Cancer diagnosis was more than 10 years ago 4. Cancer survivors/partners of survivors where the cancer treatment and follow up was not in the United Kingdom 5. Previous completion of the survey

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No intervention
No intervention

Locations

Country Name City State
United Kingdom Bournemouth University Bournemouth Dorset

Sponsors (4)

Lead Sponsor Collaborator
Bournemouth University Dorset County Hospital NHS Foundation Trust, Fortuneswell Cancer Trust, National Institute for Health Research, Applied Research Collaboration, Wessex

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of participants who had a sexual health discussion(s) with the hospital cancer team at any point during cancer care Sexual health discussion:19 examples of the sort of topics that may have been discussed in relation to sexual health Up to 10 years prior to completing survey (discussion(s) about sexual health could have occurred at any point during cancer care)
Secondary Number of participants with specific levels of impact on their sex lives by cancer and its treatments As above From each individual participants' cancer diagnosis/cancer treatment until the date that they completed the survey
Secondary Survey questionnaire to measure the nature and prevalence of care for sexual health that cancer survivors and their intimate partners self-report experiencing from the UK hospital cancer team. An online survey questionnaire (no validated questionnaire available and therefore research created the questionnaire based on a literature reviews on sexual health in oncology Participants can report care received from prior to their cancer treatment through to their follow-up care (last 10 years only)
Secondary Survey questionnaire to measure the nature and prevalence of the perceived barriers to and facilitators for care for sexual health as received by cancer survivors and their intimate partners when provided by the UK hospital cancer team. As above Participants can report their perceptions from diagnosis through to their follow-up care (last 10 years only)
Secondary Survey questionnaire to measure to what extent groups of cancer survivors and their intimate partners with differing characteristics receive differing care for their sexual health from the UK hospital cancer team. Participants' responses from outcomes 1-4 will be used toinform this outcome Participants diagnosed with cancer in the previous 10 years.
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases